REGENERON PHARMACEUTICALS's ticker is REGN and the CUSIP is 75886F107. A total of 1,128 filers reported holding REGENERON PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,910 | +105868.8% | 47 | 0.0% | 0.00% | – |
| Q3 2022 | $32 | +6.7% | 47 | -6.0% | 0.00% | – |
| Q2 2022 | $30 | -6.2% | 50 | +8.7% | 0.00% | – |
| Q1 2022 | $32 | +10.3% | 46 | 0.0% | 0.00% | – |
| Q4 2021 | $29 | -12.1% | 46 | -16.4% | 0.00% | – |
| Q3 2021 | $33 | -5.7% | 55 | -12.7% | 0.00% | – |
| Q2 2021 | $35 | +16.7% | 63 | 0.0% | 0.00% | – |
| Q1 2021 | $30 | +3.4% | 63 | +5.0% | 0.00% | – |
| Q4 2020 | $29 | -98.5% | 60 | -98.9% | 0.00% | -100.0% |
| Q1 2018 | $1,894 | -8.4% | 5,500 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $2,068 | -15.9% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,459 | -9.0% | 5,500 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $2,701 | +26.7% | 5,500 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $2,131 | +5.5% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,019 | -50.3% | 5,500 | -45.5% | 0.00% | -50.0% |
| Q3 2016 | $4,060 | +15.1% | 10,100 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $3,527 | -3.1% | 10,100 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $3,640 | -47.2% | 10,100 | -20.5% | 0.01% | -50.0% |
| Q4 2015 | $6,894 | -28.1% | 12,700 | -38.3% | 0.01% | -36.8% |
| Q3 2015 | $9,582 | -8.8% | 20,600 | 0.0% | 0.02% | 0.0% |
| Q2 2015 | $10,509 | +13.0% | 20,600 | 0.0% | 0.02% | +5.6% |
| Q1 2015 | $9,300 | +10.0% | 20,600 | 0.0% | 0.02% | +5.9% |
| Q4 2014 | $8,451 | +13.8% | 20,600 | 0.0% | 0.02% | +6.2% |
| Q3 2014 | $7,427 | -28.5% | 20,600 | -44.0% | 0.02% | -27.3% |
| Q2 2014 | $10,389 | -5.9% | 36,780 | 0.0% | 0.02% | -15.4% |
| Q1 2014 | $11,044 | +9.1% | 36,780 | 0.0% | 0.03% | +8.3% |
| Q4 2013 | $10,124 | -18.0% | 36,780 | -6.8% | 0.02% | -22.6% |
| Q3 2013 | $12,344 | +3183.0% | 39,452 | +2259.6% | 0.03% | +3000.0% |
| Q2 2013 | $376 | – | 1,672 | – | 0.00% | – |
Download | ||||||